Article
March 19, 2024
Rama Dajani, a research associate in Alex Marson's lab, discusses her early exposure to biotechnology, her research on HIV, and advice she has for women aspiring to pursue science.
Research Associates Committee
Profile
Marson Lab
Gladstone in the News
January 16, 2024
BioTechniques—Researchers at Gladstone Institutes have mapped the human immune response using next-generation CRISPR technology known as base editing. Using this tool, the team was able to identify specific nucleotides within T cells that influence immune cells’ response to stimuli, creating maps of DNA sequences and protein sites that are involved in human immune responses. The discoveries this project has facilitated could improve existing immunotherapies and reveal new drug targets for autoimmune diseases and cancer.
Research (Publication)
Autoimmune Diseases
Cancer
Genomic Immunology
Doudna Lab
Marson Lab
CRISPR/Gene Editing
Genomics
Gladstone in the News
September 19, 2023
PharmaVoice—PharmaVoice recently assembled its annual list of inspiring leaders in the industry. Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, was named to the list as a cancer care visionary, recognized for both his scientific innovation and his dedication to collaboration and mentoring.
Gladstone Experts
Genomic Immunology
Marson Lab
Gladstone in the News
April 25, 2023
Innovative Genomics Institute—Work from Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, and Affiliate Investigator Justin Eyquem demonstrates a new, more efficient and gentle method to introduce CRISPR editing machinery into cells.
Gladstone Experts
Genomic Immunology
Eyquem Lab
Marson Lab
CRISPR/Gene Editing
Gladstone in the News
January 26, 2023
Nature—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, and his colleagues have been using CRISPR to increase the therapeutic potential of T cells. This work is part of a worldwide effort to improve the design and manufacturing of cancer-killing ‟CAR-T” cells reviewed in the journal Nature.
Gladstone Experts
Cancer
Genomic Immunology
Marson Lab
CRISPR/Gene Editing
Gladstone in the News
December 23, 2022
STAT News—The Parker Institute for Cancer Immunotherapy has expanded to include a new center at Gladstone Institutes. Center Director Alex Marson says the funding will enable Gladstone scientists to take on bold, high-risk ideas and create better cell therapies for cancer.
Institutional News
Cancer
Genomic Immunology
Marson Lab
